Study directory

Mental health studies with practical context.

Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.

Back to overview
634studies shown
Showing 1-12 of 634
Drug study icon
RecruitingNCT04478838

"Extended" (Alternate Day) Antipsychotic Dosing

This study is recruiting. It focuses on schizophrenia and currently lists participation information in Canada.

In Canada
SchizophreniaOtherOver 18 Years
Countries
Canada
Sponsor
Centre for Addiction and Mental Health
Condition
Schizophrenia
Biological study icon
RecruitingNCT06856161

A Novel Blood Test as a Biomarker in Mental Health

This study is recruiting. It focuses on addiction and currently lists participation information in Canada.

In Canada
Addiction, Depression, ...OtherOver 19 Years
Countries
Canada
Sponsor
Fraser Health
Condition
Addiction, Depression, ...
Drug study icon
RecruitingNCT06072898

A Neuroimaging study of Psilocybin in Depression

This study is recruiting in Canada. It is testing randomized Neuroimaging Trial of Psilocybin for depression.

In Canada
DepressionOtherFrom 18 Years to 64 Years
Countries
Canada
Sponsor
Sunnybrook Health Sciences Centre
Condition
Depression
Other study type icon
RecruitingNCT07412756

Brenipatide in adults with Major Depressive Disorder

This study is recruiting in the United States, in Australia, in Canada, .... It is testing brenipatide for depression.

In Canada
DepressionOtherFrom 18 Years to 75 Years
Countries
United States, Australia, Canada, ...
Sponsor
Eli Lilly and Company
Condition
Depression
Drug study icon
RecruitingNCT06126224

KarXT for Schizophrenia

This study is recruiting in the United States, in Canada, in the United Kingdom, .... It is testing KarXT for Schizophrenia.

In Canada
SchizophreniaOtherFrom 55 Years to 90 Years
Countries
United States, Canada, United Kingdom, ...
Sponsor
Karuna Therapeutics, Inc., a Bristol Myers Squibb company
Condition
Schizophrenia
Other study type icon
RecruitingNCT06887192

ML-007C-MA for Schizophrenia

This study is recruiting in the United States, in France, in Canada, .... It is testing ML-007C-MA for Schizophrenia.

In Canada
SchizophreniaOtherFrom 55 Years to 90 Years
Countries
United States, France, Canada, ...
Sponsor
MapLight Therapeutics
Condition
Schizophrenia
Data coverage

Public registry coverage is progressing

HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.